Home » Topics » BioWorld Science

BioWorld Science
RSS

MicroRNA biomarkers in malignant progression of gliomas

April 24, 2020

First patient dosed in phase I study of SRF-388

April 24, 2020

Algernon receives approval for phase II COVID-19 study of ifenprodil in South Korea

April 24, 2020

FDA recommends phase III confirmatory study of bucillamine in patients with COVID-19

April 24, 2020

RECCE-327 shows significant antibacterial activity against MRSA superbug in vivo

April 24, 2020

First subject dosed in phase I study of TD-0903

April 24, 2020

AstraZeneca announces initiation of phase III DARE-19 study of Farxiga in COVID-19

April 24, 2020

ARRB1 shows a tumor-suppressive function in T-ALL by promoting NOTCH1 degradation

April 24, 2020

Cyp2c44 protects against breast tumor growth and metastasis by preventing PGE2 synthesis in mice

April 24, 2020

Favorable safety seen with MERS-CoV vaccine MVA-MERS-S in phase I study

April 24, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...